Biosafety
We are moving to electronic submission of biosafety proposals...
Studies for full or expedited review must be submitted electronically through IRBNet as of JUNE 10, 2008.

IRBNet Training materials are available at: http://www.bsu.edu/research/secure/training (please note: you will need to use your Ball State username and password to access this page).  Create a username and password (see Instructions for IRBNet Use or registration help documents on the training page). Explore the system, using the training energizer for researchers as a guide.

DO NOT REQUEST A DEMO VIA IRBNet; this is not a training application and does not pertain to your proposal!

Infectious Agents
Protocols for research projects and lab classes conducted at Ball State University involving infectious agents or materials must be registered with the BSU Institutional Biosafety Committee prior to using the infectious materials. FULL STORY

Recombinant DNA
Protocols for research projects and laboratory classes conducted at Ball State University involving Recombinant DNA molecules must be reviewed and approved by the BSU Institutional Biosafety Committee before beginning research or classwork. FULL STORY

Research Compliance Personnel Change
The Office of Research Compliance is undergoing a personnel change as Melanie Morris, Coordinator of Research Compliance, has left Ball State University for the private industry. FULL STORY
 

IBC Protocol Deadlines and Meeting Dates

IBC protocols will be reviewed at convened meetings. Your protocol must be received by the due date in order to be reviewed on the associated meeting date. If you have a time issue related to an impending grant proposal, please contact Research Compliance (ibc@bsu.edu) for assistance as soon as you are aware of the issue. Future dates will be added to this list.                 

 DEADLINE:  FOR REVIEW ON:
 TBD  TBD
space
Institutional Biosafety Committee

The Institutional Biosafety Committee (IBC) is responsible for the review of all research involving recombinant DNA molecules or the use of infectious materials.
Chair
John McKillip
Research Compliance Administrator
Amy Boos